Serum antibodies against the hepatitis C virus E2 protein mediate antibody-dependent cellular cytotoxicity (ADCC)

This publication has 20 references indexed in Scilit:

• 65 Clinical evaluation of a human monoclonal antibody against the envelope protein (E2) of HCV for prevention of HCV infection
  Journal of Hepatology, 2004
• Binding of HCV E2 to CD81 induces RANTES secretion and internalization of CC chemokine receptor 5
  Journal of Viral Hepatitis, 2004
• Expressionof Unmodified Hepatitis C Virus Envelope Glycoprotein-Coding SequencesLeads to Cryptic Intron Excision and Cell Surface Expression of E1/E2Heterodimers Comprising Full-Length and Partially DeletedE1
  Journal of Virology, 2003
• Limited Antibody‐Dependent Cellular Cytotoxicity Antibody Response Induced by a Herpes Simplex Virus Type 2 Subunit Vaccine
  The Journal of Infectious Diseases, 2000
• Antibody‐Dependent Cellular Cytotoxicity Independently Predicts Survival in Severely Immunocompromised Human Immunodeficiency Virus–Infected Patients
  The Journal of Infectious Diseases, 1999
• Antibody and Antibody-Dependent Cellular Cytotoxicity Responses against the BamHI A Rightward Open-Reading Frame-1 Protein of Epstein-Barr Virus (EBV) in EBV-Associated Disorders
  The Journal of Infectious Diseases, 1997
• A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells.
  Proceedings of the National Academy of Sciences, 1996
• A novel non-radioactive cellular cytotoxicity test based on the differential assessment of living and killed target and effector cells
  Journal of Immunological Methods, 1995
• An immunoassay for specific amplified HCV sequences
  Journal of Virological Methods, 1991
• Human T-cell lymphotropic virus IIIB glycoprotein (gp120) bound to CD4 determinants on normal lymphocytes and expressed by infected cells serves as target for immune attack.
  Proceedings of the National Academy of Sciences, 1987